MiR-24, miR-30b and miR-142-3p interfere with antigen processing and presentation by primary macrophages and dendritic cells

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Naqvi, Afsar Raza ^a   Fordham, Jezrom B ^a   Ganesh, Balaji ^a   Nares, Salvador ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD274 PROTEIN, HUMAN; MICRORNA; MIRN142 MICRORNA, HUMAN; MIRN24 MICRORNA, HUMAN; MIRN30 MICRORNA, HUMAN; PROGRAMMED DEATH 1 LIGAND 1;

ANIMAL; ANTIGEN PRESENTATION; C57BL MOUSE; DENDRITIC CELL; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOLOGY; MACROPHAGE; METABOLISM; MOUSE; PHYSIOLOGY;

ANIMALS; ANTIGEN PRESENTATION; B7-H1 ANTIGEN; DENDRITIC CELLS; GENE EXPRESSION REGULATION; HUMANS; MACROPHAGES; MICE; MICE, INBRED C57BL; MICRORNAS;

EID: 84986880082     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep32925     Document Type: Article

References (56)

1. Guilliams, M. et al. Dendritic cells, monocytes and macrophages: A unified nomenclature based on ontogeny. Nat. Rev. Immunol. 14, 571-578 (2014).
2. Underhill, D. M. & Goodridge, H. S. Information processing during phagocytosis. Nat. Rev. Immunol. 12, 492-502 (2012).
3. Flannagan, R. S., Jaumouillé, V. & Grinstein, S. The cell biology of phagocytosis. Annu. Rev. Pathol. 7, 61-98 (2012).
4. Roche, P. A. & Furuta, K. The ins and outs of MHC class II-mediated antigen processing and presentation. Nat. Rev. Immunol. 15, 203-216 (2015).
5. Blum, J. S., Wearsch, P. A. & Cresswell, P. Pathways of antigen processing. Annu. Rev. Immunol. 31, 443-73 (2013).
6. Guilliams, M., Bruhns, P., Saeys, Y., Hammad, H. & Lambrecht, B. N. The function of Fc? receptors in dendritic cells and macrophages. Nat. Rev. Immunol. 14, 94-108 (2014).
7. West, M. A. et al. Enhanced dendritic cell antigen capture via toll-like receptor-induced actin remodeling. Science 305, 1153-1157 (2004).
8. Jonas, S. & Izaurralde, E. Towards a molecular understanding of microRNA-mediated gene silencing. Nat. Rev. Genet. 16, 421-433 (2015).
9. Bartel, D. P. MicroRNAs: Target recognition and regulatory functions. Cell 136, 215-233 (2009).
10. Naqvi, A. R., Islam, M. N., Choudhury, N. R. & Haq, Q. M. The fascinating world of RNA interference. Int. J. Biol. Sci. 5, 97-117 (2009).
11. Xiao, C. & Rajewsky, K. MicroRNA control in the immune system: basic principles. Cell 136, 26-36 (2009).
12. O'Connell, R. M., Zhao, J. L. & Rao, D. S. MicroRNA function in myeloid biology. Blood 118, 2960-2969 (2011).
13. Taganov, K. D., Boldin, M. P., Chang, K. J. & Baltimore, D. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc. Natl. Acad. Sci. USA 103, 12481-12486 (2006).
14. Neilson, J. R., Zheng, G. X., Burge, C. B. & Sharp, P. A. Dynamic regulation of miRNA expression in ordered stages of cellular development. Genes Dev. 21, 578-589 (2007).
15. Li, Q. J. et al. miR-181a is an intrinsic modulator of T-cell sensitivity and selection. Cell 129, 147-161 (2007).
16. Dooley, J., Linterman, M. A. & Liston, A. MicroRNA regulation of T-cell development. Immunol. Rev. 253, 53-64 (2013).
17. Lu, T. X. et al. MicroRNA-21 limits in vivo immune response-mediated activation of the IL-12/IFN-gamma pathway, Th1 polarization, and the severity of delayed-type hypersensitivity. J. Immunol. 187, 3362-3373 (2011).
18. Wang, L. et al. Regulation of T lymphocyte activation by microRNA-21. Mol. Immunol. 59, 163-171 (2014).
19. Fordham, J. B., Naqvi, A. R. & Nares, S. Regulation of miR-24, miR-30b, and miR-142-3p during macrophage and dendritic cell differentiation potentiates innate immunity. J. Leukoc. Biol. 98, 195-207 (2015).
20. Naqvi, A. R., Fordham, J. B. & Nares, S. miR-24, miR-30b, and miR-142-3p regulate phagocytosis in myeloid inflammatory cells. J. Immunol. 194, 1916-1927 (2015).
21. Naqvi, A. R., Fordham J. B. & Nares S. MicroRNA target Fc receptors to regulate antibody-dependent antigen uptake in primary macrophages and dendritic cells. Innate Immunity In press (2016).
22. Su, X. et al. miRNomes of haematopoietic stem cells and dendritic cells identify miR-30b as a regulator of Notch1. Nat. Commun. 4, 2903 (2013).
23. Mildner, A. et al. Mononuclear phagocyte miRNome analysis identifies miR-142 as critical regulator of murine dendritic cell homeostasis. Blood 121, 1016-1027 (2013).
24. van de Berg, P. J. et al. Human cytomegalovirus induces systemic immune activation characterized by a type 1 cytokine signature. J Infect Dis. 202, 690-699 (2010).
25. Roche, P. A. & Furuta, K. The ins and outs of MHC class II-mediated antigen processing and presentation. Nat. Rev. Immunol. 15, 203-216 (2015).
26. Brown, J. A. et al. Blockade of programmed death-1 ligands on dendritic cells enhances T-cell activation and cytokine production. J. Immunol. 170, 1257-1266 (2003).
27. Keir, M. E., Butte, M. J., Freeman, G. J. & Sharpe, A. H. PD-1 and its ligands in tolerance and immunity. Annu. Rev. Immunol. 26, 677-704 (2008).
28. Francisco, L. M. et al. PD-L1 regulates the development, maintenance, and function of induced regulatory T-cells. J. Exp. Med. 206, 3015-3029 (2009).
29. Loke, P. & Allison, J. P. PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells. Proc. Natl. Acad. Sci. USA 100, 5336-5341 (2003).
30. Diao, J. et al. Immunostimulatory conventional dendritic cells evolve into regulatory macrophage-like cells. Blood 119, 4919-4127 (2012).
31. Burgdorf, S., Lukacs-Kornek, V. & Kurts, C. The mannose receptor mediates uptake of soluble but not of cell-associated antigen for cross-presentation. J. Immunol. 176, 6770-6776 (2006).
32. Burgdorf, S., Kautz, A., Böhnert, V., Knolle, P. A. & Kurts, C. Distinct pathways of antigen uptake and intracellular routing in CD4+ and CD8 T-cell activation. Science 316, 612-616 (2007).
33. Flinsenberg, T. W. et al. Fc? receptor antigen targeting potentiates cross-presentation by human blood and lymphoid tissue BDCA-3+ dendritic cells. Blood 120, 5163-5172 (2012).
34. Savina, A. et al. NOX2 controls phagosomal pH to regulate antigen processing during crosspresentation by dendritic cells. Cell 126, 205-218 (2006).
35. Jancic, C. et al. Rab27a regulates phagosomal pH and NADPH oxidase recruitment to dendritic cell phagosomes. Nat. Cell Biol. 9, 367-378 (2007).
36. Mantegazza, A. R. et al. NADPH oxidase controls phagosomal pH and antigen cross-presentation in human dendritic cells. Blood 112, 4712-4722 (2008).
37. Chapnik, E. et al. miR-142 orchestrates a network of actin cytoskeleton regulators during megakaryopoiesis. Elife 3, e01964 (2014).
38. Liu, J. et al. MiR-142-3p attenuates the migration of CD4+ + T-cells through regulating actin cytoskeleton via RAC1 and ROCK2 in arteriosclerosis obliterans. PLoS One 9, e95514 (2014).
39. Cheng, C. W. et al. MicroRNA-30a inhibits cell migration and invasion by downregulating vimentin expression and is a potential prognostic marker in breast cancer. Breast Cancer Res. Treat. 134, 1081-1093 (2012).
40. Zhang, Q. et al. Role of microRNA 30a targeting insulin receptor substrate 2 in colorectal tumorigenesis. Mol. Cell. Biol. 35, 988-1000 (2015).
41. Amelio, I. et al. miR-24 triggers epidermal differentiation by controlling actin adhesion and cell migration. J. Cell. Biol. 199, 347-363 (2012).
42. Crane, I. J. & Forrester, J. V. Th1 and Th2 lymphocytes in autoimmune disease. Crit. Rev. Immunol. 25, 75-102 (2005).
43. Raphael, I., Nalawade, S., Eagar, T. N. & Forsthuber, T. G. T cell subsets and their signature cytokines in autoimmune and inflammatory diseases. Cytokine 74, 5-17 (2015).
44. Okoye, I. S. et al. Transcriptomics identified a critical role for Th2 cell-intrinsic miR-155 in mediating allergy and antihelminth immunity. Proc. Natl. Acad. Sci. USA 111, E3081-3090 (2014).
45. Xu, S. et al. Effect of miR-142-3p on the M2 macrophage and therapeutic efficacy against murine glioblastoma. J. Natl. Cancer Inst. 106, dju162 (2014).
46. Wang, X. S. et al. MicroRNA-29a and microRNA-142-3p are regulators of myeloid differentiation and acute myeloid leukemia. Blood 119, 4992-5004 (2012).
47. Lagrange, B. et al. A role for miR-142-3p in colony-stimulating factor 1-induced monocyte differentiation into macrophages. Biochim. Biophys. Acta. 1833, 1936-1946 (2013).
48. Dahlhaus, M. et al. Expression and prognostic significance of hsa-miR-142-3p in acute leukemias. Neoplasma 60, 432-438 (2013).
49. Lv, M. et al. An oncogenic role of miR-142-3p in human T-cell acute lymphoblastic leukemia (T-ALL) by targeting glucocorticoid receptor-? and cAMP/PKA pathways. Leukemia 26, 769-77 (2012).
50. Yousef, S. et al. Immunomodulatory molecule PD-L1 is expressed on malignant plasma cells and myeloma-propagating pre-plasma cells in the bone marrow of multiple myeloma patients. Blood Cancer J. 5, e285 (2015).
51. Prodeus, A. et al. Targeting the PD-1/PD-L1 immune evasion axis with DNA aptamers as a novel therapeutic strategy for the treatment of disseminated cancers. Mol. Ther. Nucleic Acids 4, e237 (2015).
52. Iwai, Y. et al. Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade. Proc. Natl. Acad. Sci. USA 99, 12293-12297 (2002).
53. Topalian, S. L. et al. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N. Engl. J. Med. 366, 2443-2454 (2012).
54. Brahmer, J. R. et al. Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. N. Engl. J. Med. 366, 2455-2465 (2012).
55. Ansell, S. M. et al. PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma. N. Engl. J. Med. 372, 311-319 (2015).
56. Bettencourt, P. et al. Actin-binding protein regulation by microRNAs as a novel microbial strategy to modulate phagocytosis by host-cells: The case of N-Wasp and miR-142-3p. Front. Cell Infect. Microbiol. 3, 19 (2013).